Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MDH1 | P40925 | 1/20 | 0.35 |
| ▸ | MDH2 | P40926 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23071660 | 0.94 | MAPT (0.37) | MAPTALDH1A1HPGDGAAMDH1 | |
| SCHEMBL23071652 | 0.88 | GAA (0.34) | MAPTALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL18590074 | 0.88 | GAA (0.34) | MAPTALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL22202050 | 0.87 | GAA (0.34) | MAPTALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL466198 | 0.87 | GAA (0.34) | MAPTALDH1A1HPGDGAAMDH1 | |
| SCHEMBL22068557 | 0.87 | GAA (0.34) | MAPTALDH1A1HPGDGAASMN1; SMN2 | |
| SCHEMBL22068548 | 0.86 | MAPT (0.52) | MAPTALDH1A1HPGDGAAMEN1 | |
| SCHEMBL23071657 | 0.84 | MAPT (0.36) | MAPTALDH1A1HPGDGAA | |
| SCHEMBL17172384 | 0.84 | GAA (0.41) | MAPTALDH1A1HPGDGAACYP3A4 | |
| SCHEMBL14556835 | 0.82 | CYP3A4 (0.41) | MAPTALDH1A1HPGDGAAMDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220145053-A1 | Stabilized Polyolefin Compositions Comprising Benzofuranones and Hindered Phenolic Antioxidants | BASF SE (DE) | 2022-05-12 | — | — | US | disclosed |
| US-10941286-B2 | Stabilized polyolefin compositions comprising benzofuranones and hindered amine light stabilizers | BASF SE (DE) | 2021-03-09 | — | — | US | disclosed |
| US-10934423-B2 | Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers | BASF SE (DE) | 2021-03-02 | — | — | US | disclosed |
| US-10913841-B2 | Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants | BASF SE (DE) | 2021-02-09 | — | — | US | disclosed |
| US-20200216638-A1 | Stabilized Polyolefin Compositions Comprising Benzofuranones and Hindered Amine Light Stabilizers | BASF SCHWEIZ AG (CH) | 2020-07-09 | — | — | US | disclosed |
| US-20200181364-A1 | Stabilized Polyolefin Compositions Comprising Benzofuranones and Acid Scavengers | BASF SCHWEIZ AG (CH) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10941286-B2 | Stabilized polyolefin compositions comprising benzofuranones and hindered amine light stabilizers | PUF60, PARG, PARN | MAPT 140/4885ALDH1A1 1248/4885HPGD 3621/4885 |
| US-10913841-B2 | Stabilized polyolefin compositions comprising benzofuranones and hindered phenolic antioxidants | PUF60, GPX4, BPTF | MAPT 861/4885ALDH1A1 1045/4885HPGD 1499/4885 |
| US-10934423-B2 | Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers | PUF60, MORF4L1, BRPF1 | MAPT 1239/4885ALDH1A1 3588/4885HPGD 3787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.